Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28286108 | 0.82 | HSD17B10 (0.44) | ALDH1A1HSD17B10LMNAFAAHTSHR | |
| SCHEMBL2258666 | 0.80 | ALDH1A1 (0.54) | ALDH1A1HSD17B10LMNAFAAHTSHR | |
| SCHEMBL15926084 | 0.80 | ALDH1A1 (0.41) | ALDH1A1HSD17B10LMNATSHRCHRM2 | |
| SCHEMBL27990481 | 0.78 | ALDH1A1 (0.44) | ALDH1A1HSD17B10LMNATSHRSMN1; SMN2 | |
| SCHEMBL11446032 | 0.78 | ALDH1A1 (0.43) | ALDH1A1HSD17B10LMNAFAAHTSHR | |
| SCHEMBL352782 | 0.78 | — | — | |
| SCHEMBL353002 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HSD17B10TSHRTHRBMGAM | |
| SCHEMBL28840951 | 0.77 | TSHR (0.44) | ALDH1A1HSD17B10TSHRSMN1; SMN2THRB | |
| SCHEMBL352638 | 0.77 | ALDH1A1 (0.34) | ALDH1A1HSD17B10LMNAFAAHTSHR | |
| SCHEMBL6659743 | 0.77 | TSHR (0.44) | ALDH1A1HSD17B10LMNAFAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116426103-A | Polylactic acid-based environment-friendly degradable material and preparation method thereof | 江西省隆旭科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-20250188023-A1 | BENZENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-06-12 | — | — | US | disclosed |
| US-12258308-B2 | Benzene derivative | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-25 | — | — | US | disclosed |
| CN-116426103-A | Polylactic acid-based environment-friendly degradable material and preparation method thereof | 江西省隆旭科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-112513011-B | Benzene derivatives | 小野药品工业株式会社 | 2023-06-16 | — | — | CN | disclosed |
| US-20220089532-A1 | BENZENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-03-24 | — | — | US | disclosed |
| US-11261154-B2 | Benzene derivative | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-03-01 | — | — | US | disclosed |
| US-20210380635-A1 | COMPOSITIONS AND METHODS FOR PROTEIN LABELING, MODIFICATION, ANALYSIS, AND TARGETED DELIVERY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-12-09 | — | — | US | disclosed |
| US-20210332009-A1 | BENZENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2021-10-28 | — | — | US | disclosed |
| EP-3831810-A1 | BENZENE DERIVATIVE | ONO Pharmaceutical Co., Ltd. (JP) | 2021-06-09 | — | — | EP | disclosed |
| US-20120016095-A1 | a-(UNSATURATED ALKOXYALKYL) ACRYLATE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-19 | — | — | US | disclosed |
| CN-101768125-A | Triazole compound and preparation method thereof | UNIV ZHEJIANG | 2010-07-07 | — | — | CN | disclosed |
| US-20100076217-A1 | ACYLOXYLATION CATALYST AND PROCESS FOR ITS PRODUCTION | SHOWA DENKO K.K. (JP) | 2010-03-25 | — | — | US | disclosed |
| EP-2099563-A1 | ACYLOXYLATION CATALYST AND PROCESS FOR ITS PRODUCTION | Showa Denko K.K. (JP) | 2009-09-16 | — | — | EP | disclosed |
| WO-2008075588-A1 | ACYLOXYLATION CATALYST AND PROCESS FOR ITS PRODUCTION | SHOWA DENKO K.K. (JP) | 2008-06-26 | — | — | WO | disclosed |
| WO-2007070398-A1 | POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS | SCHERING CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
| EP-1123915-B1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | NIPPON CATALYTIC CHEM IND (JP) | 2004-07-28 | — | — | EP | disclosed |
| US-6541656-B2 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY, LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20010034300-A1 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY LTD. (JP) | 2001-10-25 | — | — | US | disclosed |
| EP-1123915-A1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | Nippon Shokubai Co., Ltd. (JP) | 2001-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12258308-B2 | Benzene derivative | PMP22, TMBIM6, MYT1 | ALDH1A1 1189/4885HSD17B10 3696/4885LMNA 1367/4885 |
| US-11261154-B2 | Benzene derivative | PMP22, TMBIM6, MYT1 | ALDH1A1 1189/4885HSD17B10 3696/4885LMNA 1367/4885 |
| US-20250188023-A1 | BENZENE DERIVATIVE | PMP22, TMBIM6, MYT1 | ALDH1A1 1203/4885HSD17B10 3766/4885LMNA 1430/4885 |
| US-20210380635-A1 | COMPOSITIONS AND METHODS FOR PROTEIN LABELING, MODIFICATION, ANALYSIS, AND TARGETED DELIVERY | PTMS, SRMS, CHAMP1 | ALDH1A1 3049/4885HSD17B10 4088/4885LMNA 2586/4885 |
| US-20210332009-A1 | BENZENE DERIVATIVE | PMP22, TMBIM6, MYT1 | ALDH1A1 1189/4885HSD17B10 3696/4885LMNA 1367/4885 |
| US-20220089532-A1 | BENZENE DERIVATIVE | PMP22, TMBIM6, MYT1 | ALDH1A1 1189/4885HSD17B10 3696/4885LMNA 1367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.